Required Legal Notice: Virtual currencies, real risks. The only guarantee in crypto is risk. Read more

Required Legal Notice: Virtual currencies, real risks. The only guarantee in crypto is risk. Warning: The value of your virtual currencies can rise or fall sharply, and your initial investment may be lost completely; virtual currencies are not covered by the guarantee funds that cover bank deposits; there is no legal mechanism on the virtual currencies market to prevent market manipulation or insider dealing; virtual currencies depend entirely on a specific computer technology and infrastructure, which in certain cases may be very recent and not yet adequately tested; if one loses the identification code or password giving access to the virtual wallet in which the virtual currency is stored, the currency held therein will be irretrievably lost; virtual currencies are currently accepted as a means of payment to a limited extent, and in most countries there is no legal obligation to accept them; for more information about the risks associated with an investment in virtual currencies, we advise you to read the Wikifin page What is a cryptocurrency? | Wikifin.

Equities not available in your region

Equities are currently available to U.S. only, through the Kraken app or Kraken Pro. Find out more

Home StocksCANF

Can Fite Biopharma (CANF)

AMEX

4,14 $

1,29 $ (

+45,26 %

)

Market open

CANF: 4,14 $ / ₿ 0.0001 BTC / 6903 Sats

Key statistics

Previous close

2,85 $

52 week range

2,56 $ - 21,00 $

Market Cap

8,70 млн $

Book value

2.61

Opening price

5,00 $

Trading volume

52 122 677,17 $

Shares outstanding

2,14 млн

Price / Earnings

4,14 $ - 4,16 $

Day range

3,83 $ - 5,98 $

Fractional trading

What is Can Fite Biopharma (CANF)?

Can Fite Biopharma Ltd est une société biopharmaceutique au stade clinique. La société se concentre sur le développement de médicaments à petites molécules biodisponibles par voie orale ciblant le récepteur d'adénosine A3 pour le traitement du cancer, des maladies inflammatoires, des troubles hépatiques et des affections connexes. Elle dispose d'un portefeuille de candidats-médicaments exclusifs en développement clinique de phase II et de phase III. La plateforme de la société cible le récepteur d'adénosine A3 (A3AR), qui est davantage exprimé dans les cellules inflammatoires et cancéreuses que dans les cellules normales. Ses médicaments en développement comprennent Namodenoson, Piclidenoson, CF602 et les Cannabinoïdes.

The Can Fite Biopharma (CANF) stock price has been rising

The Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) stock price today is 4,14 $, reflecting a +45,26 % move since the market opened. The company’s market capitalization stands at 8,70 млн $, with a daily trading volume of 52,12 млн $ shares. For investors tracking price trends, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares stock has ranged between 3,83 $ and 5,98 $ today. The previous closing price was 2,85 $.

Get started with Can Fite Biopharma (CANF)

Ready to get started? Follow the steps below, or read our guide on how to buy Can Fite Biopharma stock on Kraken starting from $10.

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.  

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy CANF

Search for CANF in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy CANF.

CANF FAQs

What sector is Can Fite Biopharma (CANF) in?

CANF is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

What industry is Can Fite Biopharma (CANF) in?

CANF is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

What is the 52-week high and 52-week low of Can Fite Biopharma (CANF)?

Over the past 52 weeks, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) has traded between a low of 2,56 $ and a high of 21,00 $.

What industry group is Can Fite Biopharma (CANF) in?

CANF is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Can Fite Biopharma?  Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Get the app

Amount

USD

Estimated quantity

CANF

Only available to USA clients through the Kraken app or Kraken Pro.

Kraken

Pro

USA

Buy

Explore other stocks

Most active

Explore the most-traded stocks today

Direxion Daily Semiconductor Bear 3X ETF

SOXS

Linkhome Hldgs

LHAI

Eason Technology

DXF

INLIF

INLF

ProShares Bitcoin ETF

BITO

Top gainers

Browse today’s biggest stock market winners

Alight

ALIT

2x Long VIX Futures ETF

UVIX

Bolt Projects Holdings

BSLK

Rockwell Medical

RMTI

Crown ElectroKinetics

CRKN

Top losers

Compare the worst-performing stocks of  the day

YOTAR

BGXXQ

Exela Technologies

XELA

Barrons 400 ETF

BFOR

Above Food Ingredients

ABVEF

Want to learn more about equities?

Check out our Kraken Learn Center guides

What are meme stocks?

11 min

What are stocks, exactly?

10 min

Treasury stocks, explained

6 min

Revenue vs profit

7 min

How to invest in stocks

13 min

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.

Advanced tools

Who we serve

Can Fite Biopharma (CANF)

AMEX

4,14 $

1,29 $ (